Loading…
NeOnc Technologies Holdings, Inc. is projected to rise to $4.70 by 2027, a +5% move from its current price of $4.49. NTHI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.33 | $4.49 | $4.66 | +0.09% |
| Jul 14 | $4.27 | $4.50 | $4.74 | +0.19% |
| Jul 15 | $4.22 | $4.50 | $4.80 | +0.28% |
| Jul 16 | $4.18 | $4.51 | $4.85 | +0.37% |
| Jul 17 | $4.15 | $4.51 | $4.90 | +0.47% |
| Jul 18 | $4.12 | $4.52 | $4.95 | +0.56% |
| Jul 19 | $4.10 | $4.52 | $4.99 | +0.66% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.10 | $4.52 | $4.99 | +0.66% |
| Week 2 | $3.96 | $4.55 | $5.23 | +1.32% |
| Week 3 | $3.86 | $4.58 | $5.43 | +1.98% |
| Week 4 | $3.79 | $4.61 | $5.61 | +2.65% |
| Week 5 | $3.72 | $4.64 | $5.78 | +3.32% |
| Week 6 | $3.67 | $4.67 | $5.94 | +4.00% |
| Week 7 | $3.62 | $4.70 | $6.10 | +4.68% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers.
The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.
NeOnc Technologies Holdings, Inc. is a healthcare company with a focus on intracranial malignancies. The stock trades under the ticker NTHI and has a current price of $4.51 with a market capitalization of $116.95M.
Its rank is 4125 by market cap. The current price is accompanied by a technical setup that places it in a broader risk/reward context for small-cap healthcare equities.
A major floor 15.7% below — a decisive break under it would weaken the trend.
The nearest floor, 3.1% below — buyers have tended to step in here.
The nearest ceiling, 17.4% above — a clean break opens room to run.
A major ceiling 116.7% above — clearing it would confirm fresh momentum.
Key NTHI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NTHI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.46 | Buy | $4.48 | Buy |
| MA 10 | $4.47 | Buy | $4.51 | Sell |
| MA 20 | $4.65 | Sell | $4.60 | Sell |
| MA 50 | $4.83 | Sell | $5.00 | Sell |
| MA 100 | $6.14 | Sell | $5.85 | Sell |
| MA 200 | $7.79 | Sell | $6.89 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.33 | Neutral |
| Stoch RSI (14) | 31.10 | Neutral |
| CCI (20) | -47.99 | Neutral |
| Williams %R (14) | -81.58 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -7.99 | Sell |
| Bollinger %B (20,2) | 0.35 | Neutral |
| Stochastic %K (14) | 18.42 | Buy |
| TRIX (15) | -0.35 | Sell |
| Awesome (5,34) | -0.22 | Sell |
| Ultimate (7,14,28) | 39.61 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 4.47 | Buy |
| ADX (14) | 12.99 | Neutral |
| ATR (14) | 0.14 | Info |
The near-term technical picture is NEUTRAL. The RSI14 is 40, and the stock sits between its 50-day moving average of $4.93 and its 200-day moving average of $8.09. Support is identified at $4.35 and resistance at $5.50, framing a 30-day range from $3.28 to $6.20. Annualized volatility sits at 90%, highlighting notable price fluctuations within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.06 | $4.49 | $6.18 | 0% | Neutral | |
| $3.56 | $4.70 | $6.66 | +5% | Neutral | |
| $4.09 | $5.64 | $8.42 | +26% | Bullish | |
| $4.50 | $6.45 | $10.03 | +44% | Bullish | |
| $3.76 | $5.57 | $8.96 | +24% | Bullish | |
| $3.53 | $5.40 | $8.94 | +20% | Bullish | |
| $3.62 | $5.71 | $9.69 | +27% | Bullish | |
| $3.42 | $5.54 | $9.63 | +23% | Bullish | |
| $4.14 | $6.89 | $12.24 | +54% | Bullish | |
| $4.41 | $7.54 | $13.65 | +68% | Bullish | |
| $4.56 | $8.79 | $17.27 | +96% | Bullish | |
| $6.52 | $14.48 | $31.93 | +222% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.06 | $4.49 | $5.50 | +0.00% |
| August 2026 | $4.03 | $4.83 | $5.99 | +7.56% |
| September 2026 | $4.04 | $4.89 | $6.16 | +1.24% |
| October 2026 | $3.83 | $4.68 | $5.97 | -4.38% |
| November 2026 | $3.78 | $4.66 | $6.02 | -0.33% |
| December 2026 | $3.82 | $4.74 | $6.18 | +1.65% |
Click any year to see its month-by-month NTHI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NTHI price prediction for 2026 points to an average of $4.49 (low $4.06, high $6.18) — a potential gain of 0% on today's $4.49. Price action looks broadly range-bound.
In 2027, NTHI is projected to trade between $3.56 and $6.66, averaging $4.70 — a potential gain of +5% from today's $4.49. That is up +5% on the projected 2026 average. A consolidation phase looks the most probable path here.
NeOnc Technologies Holdings, Inc.'s 2028 outlook centres on $5.64, within a $4.09 to $8.42 range. That is up +20% on the projected 2027 average. That marks a +26% change versus current levels. Momentum favours further upside here.
By 2029, NTHI could reach as high as $10.03, with a base case around $6.45 and support toward $4.50 — roughly +44% from $4.49. Buyers look set to stay in control over this stretch.
Expect NTHI to range from $3.76 to $8.96 through 2030. The $5.57 average target implies a +24% move from current prices. That is -14% versus the projected 2029 average. Momentum favours further upside here.
The NTHI price prediction for 2031 points to an average of $5.40 (low $3.53, high $8.94) — a potential gain of +20% on today's $4.49. Buyers look set to stay in control over this stretch.
In 2032, NTHI is projected to trade between $3.62 and $9.69, averaging $5.71 — a potential gain of +27% from today's $4.49. That is up +6% on the projected 2031 average. Momentum favours further upside here.
NeOnc Technologies Holdings, Inc.'s 2033 outlook centres on $5.54, within a $3.42 to $9.63 range. That is -3% versus the projected 2032 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, NTHI could reach as high as $12.24, with a base case around $6.89 and support toward $4.14 — roughly +54% from $4.49. Momentum favours further upside here.
Expect NTHI to range from $4.41 to $13.65 through 2035. The $7.54 average target implies a +68% move from current prices. That is up +9% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The NTHI price prediction for 2040 points to an average of $8.79 (low $4.56, high $17.27) — a potential gain of +96% on today's $4.49. Momentum favours further upside here.
In 2050, NTHI is projected to trade between $6.52 and $31.93, averaging $14.48 — a potential gain of +222% from today's $4.49. That is up +65% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NTHI today (≈ 222.717149 NTHI) could be worth
$3,224.93
+$2,224.93 (+222%) by 2050 · US Dollar
Based on the average projected NTHI price of $14.48 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NTHIwould be worth at today's price.
$1,000 invested in NTHI on Jul 10, 2025 (≈ 204.918028 NTHI) would be worth
$920.08
-$79.92 (-8.0%) today · 0.92× · US Dollar
Based on a NTHI entry price of $4.88 vs. today's $4.49.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.42 | $1,015.84 | +1.6% |
| 1 month ago | $4.55 | $986.81 | -1.3% |
| 3 months ago | $5.44 | $825.37 | -17.5% |
| 6 months ago | $9.65 | $465.28 | -53.5% |
| 1 year ago | $4.88 | $920.08 | -8.0% |
| All time (1.3y) ago | $12.11 | $370.77 | -62.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NTHI forecast.
Our base-case forecast reaches $9.00 around 2050.
Implied market cap at $9.00: $233.39M
The multi-year forecast shows a bullish drift starting in 2028 and extending through 2050. In 2030 the average price is projected to be $5.65 with a min of $3.44, a max of $9.94, and a return on investment of 25.4%. The forecast for 2040 points to an average of $9.64 with a max of $21.51 and a substantial 113.7% ROI, signaling a meaningful upside under the bullish scenario.
By 2050 the average price is forecast at $14.66 with a max of $33.71 and an expected ROI of 225%, reflecting continued bullish sentiment. The path from 2028 onward shows repeated bullish signals, while early years (2026-2027) are neutral; the forecast explicitly notes bullish momentum for the late 2020s through 2050. These are estimates, not guarantees, and depend on market and regulatory conditions as well as other factors that influence valuation.
Tap a question to reveal the answer.
2030 avg $5.65, min $3.44, max $9.94; ROI 25.4%; sentiment BULLISH.
Forecasts show neutral in 2026 and 2027, turning bullish from 2028 onward with notable upside: 2028 avg $6.15 (ROI 36.4%), 2029 avg $6.97 (ROI 54.5%), 2030 avg $5.65 (ROI 25.4%), 2040 avg $9.64 (ROI 113.7%), and 2050 avg $14.66 (ROI 225%). These are estimates, not guarantees.
Yes. The forecast includes 2035 max of $16.46 and 2040 max of $21.51, while 2030 avg is $5.65. This indicates potential for prices to exceed $10 under the projected scenarios.
Current price is $4.51 and market capitalization is $116.95M.
The 30-day picture shows Neutral sentiment, RSI14 at 40, SMA50 at $4.93, SMA200 at $8.09. Support is at $4.35 and resistance at $5.50, with a 30-day range of $3.28 to $6.20.
NeOnc Technologies Holdings, Inc. Community Discussion
0Share your NeOnc Technologies Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.